Floatz logo

ec5026

Spinal Stenosis

EicOsis Human Health Inc.Small moleculePhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

0 Active assets in the Spinal Stenosis cohort.

Asset / SponsorPhaseRating
FENTANYL
Seoul National University Hospital
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Seoul National University Hospital
Phase 4B

Same molecule, other indications

ec5026 is also rated in:

Parkinson diseaseDormant
CCC
Indicative ·
48 / 100
View asset →
spinal cord injuryDormant
CC
Indicative ·
43 / 100
View asset →
lumbar disk degenerative disorderDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →